Welcome : Guest

NephroGenex, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about NephroGenex, Inc., which is principally involved in Pharmaceuticals Business. Illustrated with 33 tables, the report showcases the company's recent news stories and events, key markets and market position as against its competitors operating in the industry.

Code: PCP-64972
Price: $1650
Company Type: Public
Pages: 35
Date: March 2016
Market Data Tables: 33

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Diabetes Drugs......2
Table 1: Diabetes Drug Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-4 Inhibitor, GK Activator, GLP-1 Agonist, GPCR Agonist, IL- Receptor Antagonist, Insulin Analogue, PPAR Agonist, SGLT-2 Inhibitor, and Others......2
Table 2: Antidiabetes Molecules Market by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Metformin, Sulfonylureas, Thiazolidin Ediones and Others......3
Table 3: Anti-Diabetic Drug Market by Treatment Class Worldwide (2014) - Percentage Share Breakdown by Value for Diet & Exercise, Incretion, Insulin and Oral Anti-Diabetic......4
Table 4: Diabetes/Metabolic Drugs Market by Category Worldwide (2014) - Percentage Breakdown by Value Sales for DPP-IV Inhibitors, Glitazones, GLP-1 Analogs, Insulins, Sulfonylureas, and Others......5
Table 5: Diabetes Drugs Market by Product Category in China (2015) - Percentage Share Breakdown by Value for Acarbose, Insulin, Melbine, and Other Diabetes Drugs......6
Table 6: Anti-Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Insulin Drugs and Non-Insulin Drugs......7
Table 7: Oral Diabetes Medicine Market in the US (2015) - Percentage Share Breakdown by Value Sales for Dipeptidyl Peptidase-4 (DPP4), Metformin, Sulfonylureas, and Others......8
Diabetes Market......9
Table 8: Diabetes Market by Region Worldwide (2015) - Percentage Share Breakdown for Africa, Europe, Middle East & North Africa, North America & Caribbean, Southeast Asia, and Western Pacific......9
Table 9: Diabetes Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Insulin Type-1 Diabetes, Insulin Type-2 Diabetes, Dipeptidyl Peptidase 4, (DPP4), Glucagon-like Peptide-1 (GLP-1), Dipeptidyl Peptidase 4, (DPP4) + Biguanide, and Others......10
Table 10: Type II Diabetes Market by Insulin Treatment Worldwide (2015) - Percentage Share Breakdown by Value for Diet and Exercise Only, Insulin and Orals and Insulin Only......11
Table 11: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown for Insulin Pumps, and Multiple Daily Injections......12
Table 12: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown by Value for Type 1, and Type 2......13
Table 13: No. of Diabetes Patients by Medication in the US (2014) - Percentage Share Breakdown for Insulin and Oral Medication, Insulin Only, No Medication, and Oral Medication Only......14
Table 14: Type 1 Diabetes Market by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Continuous Glucose Monitoring Users, and Non-Continuous Glucose Monitoring Users......15
Table 15: Type 1 Diabetes Market by Medical Device in the US (2015) - Percentage Share Breakdown by Value for Insulin Pumps and Multiple Daily Injections......16
Table 16: Diabetes Healthcare Market by Category in the US (2015) - Percentage Share Breakdown by Value for Anti -Diabetic Agents & Supplies, Doctor Office Visits, Hospital Care, Nursing/Residential Facility Stays, Prescription Medication, and Others......17
Kidney Disease Drugs......18
Table 17: Kidney Disease Market by Drug in the US (2014) - Percentage Share Breakdown by Value Sales for Aranesp and Others......18
Table 18: Traditional Chinese Medicine (TCM) Market for Kidney Ailments by Drug in China (2014) - Percentage Share Breakdown by Value Sales for Ambrette Capsule, Haikunshenxi Capsule, Shenyankangfu Tablet, Uremic Clearance Granule, Yinhuamiyangling and Others......19
Dialysis Drugs......20
Table 19: Dialysis Market by Drug in the US (2014) - Percentage Share Breakdown by Value Sales for Aranesp, EPO alfa/beta biosimilars and Others......20
Table 20: Dialysis Product Market by Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Hemodialysis Products, and Peritoneal Dialysis Products......21
Hemodialysis Drugs......22
Table 21: Hemodialysis Market by Drug in the US ((2014) - Percentage Share Breakdown by Value Sales for Aranesp, Epogen, and Others......22
Kidney Disease Market......23
Table 22: New Patients with Kidney Failure by Cause in the US (2015) - Percentage Share Breakdown by Volume for Diabetes, High Blood Pressure and Others......23
Table 23: Chronic Kidney Disease Market by Drug in the US (2014) - Percentage Share Breakdown by Value Sales for Aranesp and Others......24
Dialysis Patients......25
Table 24: No. of Dialysis Patients by Category in China (2014) - Percentage Market Share Breakdown by Volume for Haemodialysis Patients, and Peritoneal Dialysis Patients......25
Table 25: No. of Dialysis Patients by Category Worldwide (2015) - Percentage Market Share Breakdown by Volume for Haemodialysis Patients, Peritoneal Dialysis Patients, and Transplant patients......26
Table 26: No. of Dialysis Patients by Geographic Region Worldwide (2015) - Percentage Share Breakdown for Europe, Japan, Rest of World (RoW), and USA......27
Table 27: No. of Dialysis Patients by Region Worldwide (2015) - Percentage Market Share Breakdown by Volume for Asia-Pacific, Europe, the Middle East and Africa (EMEA), Latin America, and North America......28
Table 28: No. of Dialysis Patients by Treatment Type Worldwide (2015) - Percentage Market Share Breakdown by Volume for Hemodialysis, and Peritoneal Dialysis......29
Diabetes Drugs......30
Table 29: Market Shares of Leading Anti-Diabetic Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Abbott Healthcare Pvt Ltd., Biocon Limited, Lupin Pharmaceuticals, Inc., MSD Pharmaceuticals Private Limited, Sanofi-Aventis Groupe, Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., and Others......30
Table 30: Market Shares of Leading Diabetes Care Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Bristol-Myers Squibb (Incl Amylin), Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk A/S, Sanofi S.A. and Others......31
Table 31: Market Shares of Leading Diabetes Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......32
Dialysis Services......33
Table 32: Market Shares of Leading Dialysis Service Providers Worldwide (2015) - Percentage Share Breakdown by Value for Fresenius SE & Co. KGaA, DaVita Healthcare Partners, Inc. and Others......33
Table 33: Market Shares of Leading Dialysis Service Providers by Value Sales in the US (2014) - Percentage Breakdown for DaVita Healthcare Partners, Inc., Fresenius SE & Co. KGaA, and Others......34